FLGT  valuation analysis

Basics
Name: Fulgent Genetics, Inc
Description: Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Mar 04, 2021
Market cap: $2.51B (984th)
Sales(TTM): $421.71M (1244th)
Earnings(TTM): $214.31M (549th)

Value
FFER: 0.71 (why)
Actual price: $88.95
FFEThis is Fulgent Genetics, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $135.01
Quantile: FLGT is cheap given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Fulgent Genetics, Inc's earnings increased from -$411,000 to $214.31M in the last year.
  • Fulgent Genetics, Inc's sales grew by 1196.5% ($32.53M to $421.71M) over one year against a market average growth of 31.2%.
  • Fulgent Genetics, Inc's operating income increased from -$428,000 to $290.16M in the last year.
Earnings / MarketCap
Fulgent Genetics, Inc
"Diagnostics & Research" industry
Sales / MarketCap
Fulgent Genetics, Inc
"Diagnostics & Research" industry
Book / MarketCap
Fulgent Genetics, Inc
"Diagnostics & Research" industry
Equity / Assets
Fulgent Genetics, Inc
"Diagnostics & Research" industry